Medgend Icon

Ledgend of Medicine







discontinued


Lynparza FDA Approved Drugs

LYNPARZA [OlaparibC24H23FN4O3]
RX
-
50mg (oral capsule)
Astrazeneca PharmsDec 19, 2014
  • Treatment of brca mutated ovarian cancer using parp inhibitor.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.